<< Ranbaxy and Pfizer settle on Lipitor patent litigation | Reverse shoulder surgery >>
Read in | English | Español | Français | Deutsch | Português | Italiano | 日本語 | 한국어 | 简体中文 | 繁體中文 | Nederlands | Русский | Svenska | Polski

AutoGenomics issued European patent for Human papillomavirus

Published on June 19, 2008 at 4:30 AM · No Comments

AutoGenomics has announced that it has been issued a key European patent for Human papillomavirus.

Patent No.1 499 749 B1, "Human papillomavirus Detection with DNA Microarray," claims to be a method for detecting the presence of HPV using a microarray.

"This patent is the result of our collaboration with Dr. Erik Thunnissen, a prominent clinician and opinion leader in the field of Human papillomavirus," said Mr. Fareed Kureshy, President and CEO of AutoGenomics.

He further said that "with increasing demands for alternative technologies to meet the evolving need for genotyping we are excited that we can offer an automated solution that can significantly enhance workflow efficiency in the laboratory".

http://www.autogenomics.com/

Posted in: Medical Patent News

Tags: , ,

Comments
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.



  Country flag

biuquote
  • Comment
  • Preview
Loading